A detailed history of Balyasny Asset Management LLC transactions in Taro Pharmaceutical Industries LTD stock. As of the latest transaction made, Balyasny Asset Management LLC holds 13,444 shares of TARO stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,444
Holding current value
$0
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$40.97 - $43.33 $550,800 - $582,528
13,444 New
13,444 $569,000
Q1 2023

May 15, 2023

BUY
$23.0 - $31.59 $323,288 - $444,029
14,056 New
14,056 $341,000
Q1 2018

May 15, 2018

SELL
$95.91 - $107.26 $198,725 - $222,242
-2,072 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$104.5 - $126.38 $216,524 - $261,859
2,072
2,072 $217,000

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.